Vaccine-Preventable Diseases: all 53 studies
Page 1 of 1. Open to participants first (12), then studies with results posted, then the rest; newest registration first within each.
- Single-center, Open-label Study: Immunogenicity and Safety Observation After Vaccination With ACYW135 Meningococcal Polysaccharide Vaccine in Junior High School Students Aged 13-15 YearsNot yet recruitingNCT07885371Phase 4
- Maternal Immunization With Tetanus Toxoid, Reduced Diphtheria Toxoid, Reduced-dose (2 µg) Recombinant Pertussis Vaccine (TdaP2gen) and Its Effect on the Immune Response in Thai Infants up to 15-18 Months OldNot yet recruitingNCT07621341Phase 4
- Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health PerspectiveRecruitingNCT07358910
- Addressing Unfunded Vaccines Through a Co-payment Mechanism in PharmaciesRecruitingNCT06489964Not applicable
- Collaborative Open Research Initiative Study (CORIS-1)Not yet recruitingNCT06357650
- Fine Needle aSpiration of Lymph nodEs to Study vAccine-induced ImmunityRecruitingNCT06202703Not applicable
- A Phase Ⅲ Clinical Study to Evaluate Protective Efficacy and Safety of a Recombinant Herpes Zoster VaccineRecruitingNCT06088745Phase 3
- Animal Bite Victims Seeking Medical Services at Concerned HospitalsNot yet recruitingNCT06054581
- Playing Game to Learn About Children's Vaccine ProjectRecruitingNCT05984849Not applicable
- The Immune Responses After Hepatitis B Revaccination Doses in a Young CohortRecruitingNCT04970836Not applicable
- Adding Male Single Dose HPV Vaccination to Female HPV Vaccination in TanzaniaRecruitingNCT04953130Phase 4
- Measles and BCG Vaccines for Mother and ChildRecruitingNCT04899765Phase 4
- Building Engagement Using Financial Incentives Trial - Colorectal Cancer ScreeningCompletedNCT06124131Not applicableResults posted
- Culturally Tailored HPV Psychoeducational Multimedia InterventionCompletedNCT06098690Not applicableResults posted
- The Efficacy of the 2023-2024 Updated COVID-19 Vaccines Against COVID-19 InfectionCompletedNCT06065176Phase 4Results posted
- Trial of the Immunogenicity, Safety, and Tolerability of rF1V Vaccine With CpG 1018® Adjuvant Compared With rF1V Vaccine in Adults 18 to 55 Years of AgeCompletedNCT05506969Phase 2Results posted
- A Phase 2 Bridging Study to Assess the New Formulation of ETVAXCompletedNCT05178134Phase 2Results posted
- Effect of Varied Outreach Methods on Appointment Scheduling, Appointment Completion, and Receipt of COVID-19 VaccinationCompletedNCT04904744Not applicableResults posted
- Effect of Varied Outreach Methods on Appointment Scheduling, Appointment Completion, and Receipt of MMR VaccinationCompletedNCT04567342Not applicableResults posted
- Using BCG to Protect Senior Citizens During the COVID-19 PandemicCompletedNCT04542330Phase 3Results posted
- Implementation Research Zero-dose and Under-immunized ChildrenCompletedNCT07928115Not applicable
- Long-term Immunogenicity of L-HAV Vaccine Among Healthy Thai Children and AdolescentsActive, not recruitingNCT07032610
- Immunogenicity and Safety of I-HAV in Healthy Thai Children and Adolescents Lacking Protective Antibody After L-HAVActive, not recruitingNCT06978621Phase 3
- Vaccine Hesitancy in Patients with Solid Tumors: a Cross-sectional Single-center SurveyCompletedNCT06872814
- Impact of Reactogenicity of the 2024-2025 COVID-19 Vaccines on Health Care Workers and First Responders in the United StatesCompletedNCT06633835Phase 4
- Safety and Immunogenicity of Two Dose Levels of OVX836 Influenza Vaccine as a Booster on Participants Previously Administered With OVX836CompletedNCT06582277Phase 2
- Safety and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adults 50 Years of Age and OverActive, not recruitingNCT06569823Phase 1/2
- Study to Evaluate the Safety and Immunogenicity of an HIV-1 Vaccine Regimen of Adjuvanted UVAX-1107 Followed by Adjuvanted UVAX-1107 or Adjuvanted UVAX-1197 in Healthy Subjects Aged 25-55 Years.CompletedNCT06541093Early Phase 1
- Immunogenicity and Safety of Inactivated and Live-attenuated HAV Vaccine Among Thai Healthy Children and AdolescentsCompletedNCT06298708Phase 3
- Game-Based Intervention to Promote HPV VaccinationCompletedNCT06162676Not applicable
- A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Prophylactic Hepatitis B VaccineCompletedNCT06147895Phase 1
- Safety and Immunogenicity of CVI-VZV-001 for Prevention of Herpes Zoster in Healthy Adults Age 50 Years and AboveCompletedNCT06137755Phase 1
- Immune Response Elicited by Concomitant Administration of Oral Typhoid Fever (Vivotif®) and Cholera (Dukoral®) VaccinesCompletedNCT06104345Phase 4
- Improving Vaccine Counseling Skills Among Residents Using Educational Modules and Standardized Patient EncountersCompletedNCT06074237Not applicable
- Reducing COVID-19 Vaccine Hesitancy Among Hispanic ParentsCompletedNCT06036134Not applicable
- A Study to Evaluate Safety and Tolerability of a Recombinant Herpes Zoster VaccineStatus unknownNCT05750017Phase 1
- Herpes Virus Infections in Kidney Transplant PatientsActive, not recruitingNCT05604911
- Volatility and Heterogeneity of Vaccine Sentiments Means Continuous Monitoring is Needed When Measuring Message EffectivenessCompletedNCT05499299Not applicable
- Impact of Catch-up HPV VaccinationTerminatedNCT05462249
- Effectiveness, Immunogenicity and Safety of the Second Booster Dose of the Vaccine Against COVID-19 in the ElderlyCompletedNCT05283902
- Trial to Evaluate the Safety, Tolerability, and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adult VolunteersCompletedNCT05245838Phase 1
- Hashtag HPV: HPV Vaccine Twitter Education ProgramCompletedNCT05204030Not applicable
- Safety and Immunogenicity of 2 Doses Versus 1 Dose of Acellular Pertussis Vaccines Containing Genetically-detoxified Pertussis Toxin in Young Adults Previously Primed With Acellular Pertussis VaccinesStatus unknownNCT05193734Phase 2/3
- Pneumococcal Vaccination in Patients With Chronic Lymphocytic LeukaemiaStatus unknownNCT05145101
- Assess the Safety and Immunogenicity of PNEUMOSIL® Vaccine in Healthy Vietnamese Children, 6 Weeks to 24 Months of AgeStatus unknownNCT05140720Not applicable
- Study of Gam-COVID-Vac in AdolescentsStatus unknownNCT04954092Phase 2/3
- COVID-19 Antibody Levels After VaccinesCompletedNCT04944134
- Iron and Vaccine ResponseCompletedNCT04912661Not applicable
- COVID-19 Vaccine For Indirect ProtectionWithdrawnNCT04818736Phase 4
- Seroprevalence of Neutralizing Antibodies Against Japanese Encephalitis Virus Among 6 Years Old Children With 5 Different Immunization Strategies in Zhejiang ProvinceStatus unknownNCT04817917Phase 4
- An Evaluation of a Dynamic Web-Based Visualization of Community ImmunityCompletedNCT04787913Not applicable
- Community-Engaged Bidirectional Pandemic Crisis and Emergency Risk Communication With COVID-19 Vaccine Messages to Minority PopulationsCompletedNCT04765839Not applicable
- Testing the Use of Prompts to Increase Adolescent Immunization RatesCompletedNCT01984125Not applicable